Sure, Eli Lilly’s Tirzepatide-based drugs have caught up significantly to Novo Nordisk’s semaglutide-based ones. As a result, ...

Médicos y farmacéuticos han coincidido en destacar el papel de la farmacia en el abordaje integral de la obesidad por su ...

On Tuesday, Novo's top investor, the non-profit Novo Nordisk Foundation, moved to take control of the company's board. It ...

Discover how potential U.S. price cuts on obesity drugs could impact LLY and NVO revenues, stock sentiment, and valuation ...

After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular ...

Pressured by its key shareholder, the Novo Nordisk Foundation, the company said its chairman, Helge Lund, will resign. In addition to Lunde, the company's vice chair, Henrik Poulsen, will step down, ...

Novo Nordisk shares slumped Friday after President Trump said he would lower the price of the Danish company's Ozempic drug for Americans. Speaking in the Oval Office Thursday, Trump said the cost of ...

Novo Nordisk shares fell as much as 6.4% in early Friday trade after U.S. President Donald Trump signalled the price of the Danish drugmaker's weight-loss drugs would be lowered. Ciara Lee reports.

Novo Nordisk shares dropped 6.4% and Eli Lilly fell over 5% after President Trump said Ozempic prices could drop from $1,000 to $150 per month Trump made comments during a White House press briefing ...

NEW YORK (AP) — Armed with hundreds of thousands of dollars from Newman’s Own Foundation and Ozempic creator Novo Nordisk, young Native Americans are leading the fight against persistently high rates ...